Key pre-clinical data on oculopharyngeal muscular dystrophy (OPMD) published in Nature Communications Apr 3, 2017 | Press Release Benitec Biopharma Limited (ASX:BLT; NASDAQ: BNTC; NASDAQ: BNTCW) is pleased to announce that the initial pre-clinical efficacy results of the OPMD program have been published in Nature Communications, an open access scientific journal published by the Nature Publishing Group
